Symptoms, Imaging, and the Diagnostic Journey
At a Glance
Intraductal breast papillomatosis may cause nipple discharge or a lump, but many cases are found during screening. Imaging locates the abnormality, while a needle biopsy confirms it; doctors then check that the biopsy explains the images before deciding on monitoring or more tissue removal.
The path to a diagnosis of intraductal breast papillomatosis often begins with a symptom you noticed or a finding on a routine screening. Because these growths live inside the milk ducts and are often very small, your doctors must use a combination of detailed imaging and tissue samples to understand exactly what is happening [1][2].
It is important to remember that while imaging provides a “map” of your breast, it cannot provide a final diagnosis. A biopsy—taking a small physical sample of the tissue—is the only way to confirm if a growth is a benign papilloma or something else [3][4].
How Papillomatosis Presents
Symptoms of papillomatosis vary depending on where the growths are located.
- Nipple Discharge: This is a symptom compatible with papilloma, particularly central lesions. The discharge is most concerning when it happens spontaneously (without squeezing the breast) and is bloody, though it can also be clear or serous (yellowish) [2]. Spontaneous unilateral bloody discharge always requires evaluation [5][6].
- A Palpable Mass: You or your doctor might feel a small, firm lump, particularly if the papilloma is located near the nipple [2][1].
- No Symptoms at All: Many cases of multiple papillomas are “silent.” They are found deeper in the breast tissue during a routine mammogram and do not cause any pain or discharge [1][3].
Imaging: Mapping the Ducts
If a papilloma is suspected, your care team will use specific tools tailored to the actual finding. No single imaging modality is universally “best.”
Mammogram (or Tomosynthesis)
Mammography is particularly important for calcifications. Papillomatosis may appear as small clusters of microcalcifications (tiny calcium deposits) or as an architectural distortion, where the breast tissue looks slightly pulled or bunched up [2][3]. Because these patterns can also be seen in more serious conditions, they always require follow-up [2].
Ultrasound
Ultrasound is useful for a sonographic mass or a duct abnormality. The radiologist looks for a hypoechoic mass—a dark spot on the screen—sitting inside a dilated duct (a milk duct that has been stretched open by the growth) [7][8]. They may also use Doppler ultrasound to look for blood flow (vascularity); while this helps distinguish a solid papilloma from a simple fluid-filled cyst, it is not definitively diagnostic on its own [9].
MRI
An MRI is generally reserved for selected problem-solving, assessing the extent of disease, or screening patients who already meet high-risk criteria. On an MRI, papillomas may appear as enhancing masses, but this finding is not specific for a papilloma [4][10].
The Biopsy Process
Once a suspicious area is found on imaging, a biopsy is performed. For papillomatosis, this is usually done using a needle while the doctor watches the area on an ultrasound or mammogram screen.
- Core Needle Biopsy (CNB): A hollow needle is used to take several small “cores” of tissue.
- Vacuum-Assisted Biopsy (VAB): This uses a slightly larger, specialized needle that uses gentle suction to pull more tissue into the needle. VAB is often preferred because it provides a larger sample, which is especially helpful for evaluating microcalcifications and ensuring the pathologist is certain of the diagnosis [11][12].
The Risk of Underestimation (Upgrade)
A needle biopsy only takes a small sample of the growth. There is a risk of underestimation (also called an upgrade), where the small sample looks benign, but a larger sample (taken during surgery) might reveal something more serious, like atypia, DCIS, or invasive cancer [13][14].
It is important to understand what these study-specific percentages mean:
- For strictly defined, concordant, benign solitary papillomas without atypia, the risk of an upgrade to cancer is low, estimated at 1.4% in a meta-analysis [15].
- If the biopsy already shows atypia, the risk of finding a more serious malignancy at excision is much higher, often between 20% and 36% in pooled studies [14][16].
- These rates vary with patient selection, biopsy technique, and multiplicity; a solitary benign rate may not apply perfectly to multifocal disease.
The Gold Standard: Radiology-Pathology Concordance
After your biopsy, your doctors perform a final correlation check called radiology-pathology concordance [17][18]. They ask: “Does the laboratory result (the pathology) explain what we saw on the pictures (the radiology)?”
- Concordant: The biopsy showed a benign papilloma, and that adequately explains the mass or calcifications on the mammogram. If your results are concordant and “without atypia,” you may be evaluated for observation with imaging instead of surgery [15][19].
- Discordant: The biopsy shows something benign, but the imaging looks very suspicious, or the team isn’t sure they sampled the right calcifications. In these cases, even if the biopsy result says “benign,” your doctor will likely recommend a repeat biopsy or surgical removal [17][12].
Common questions in this guide
What symptoms can intraductal breast papillomatosis cause?
What can a mammogram or ultrasound show with breast papillomatosis?
Is breast imaging enough to diagnose an intraductal papilloma?
What is the difference between a core needle biopsy and a vacuum-assisted biopsy?
What does it mean if my biopsy and breast imaging are concordant?
How often can a breast papilloma biopsy be upgraded to a more serious diagnosis?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on intraductal breast papillomatosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is my biopsy result considered 'concordant' with my imaging findings by the multidisciplinary team?
- 2.Was my biopsy performed using a standard core needle or a vacuum-assisted device?
- 3.What percentage of the lesion seen on imaging was removed during the biopsy?
- 4.If my mammogram showed microcalcifications, does the pathology confirm those specific areas were successfully sampled?
- 5.Given my multiple lesions and symptoms, what is the expected 'upgrade rate' for someone in my specific situation?
References
References (19)
- 1
Papillomas of the breast: factors associated with underestimation.
Boufelli G, Giannotti MA, Ruiz CA, et al.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2018; (27(4)):310-314 doi:10.1097/CEJ.0000000000000343.
PMID: 28296665 - 2
A retrospective observational study of intraductal breast papilloma and its coexisting lesions: A real-world experience.
Li X, Wang H, Sun Z, et al.
Cancer medicine 2020; (9(20)):7751-7762 doi:10.1002/cam4.3308.
PMID: 32822113 - 3
Spectrum of imaging findings of papillary breast disease: A radiopathological review in a tertiary center.
Fadzli F, Rahmat K, Ramli MT, et al.
Medicine 2021; (100(16)):e25297 doi:10.1097/MD.0000000000025297.
PMID: 33879660 - 4
Magnetic resonance imaging features for differentiating breast papilloma with high-risk or malignant lesions from benign papilloma: a retrospective study on 158 patients.
Wang LJ, Wu P, Li XX, et al.
World journal of surgical oncology 2018; (16(1)):234 doi:10.1186/s12957-018-1537-9.
PMID: 30558621 - 5
Ductal carcinoma in situ of the breast arising in a solitary intraductal papilloma.
Badrawi N, AlSayegh AA
Radiology case reports 2023; (18(2)):449-451 doi:10.1016/j.radcr.2022.11.014.
PMID: 36439917 - 6
Management of benign papilloma without atypia diagnosed at ultrasound-guided core needle biopsy: Scoring system for predicting malignancy.
Ahn SK, Han W, Moon HG, et al.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2018; (44(1)):53-58 doi:10.1016/j.ejso.2017.10.214.
PMID: 29174198 - 7
Diagnosis of Nipple Discharge: Value of Magnetic Resonance Imaging and Ultrasonography in Comparison with Ductoscopy.
Yılmaz R, Bender Ö, Çelik Yabul F, et al.
Balkan medical journal 2017; (34(2)):119-126 doi:10.4274/balkanmedj.2016.0184.
PMID: 28418338 - 8
Ultrasound characteristics comparison and development of a predictive nomogram for intraductal papilloma and ductal carcinoma in situ: a retrospective cohort study.
Su L, Xie Q, Yi A, et al.
Frontiers in oncology 2025; (15()):1454951 doi:10.3389/fonc.2025.1454951.
PMID: 40313250 - 9
Using the Superb Microvascular Imaging Method in the Distinction of Intraductal Papilloma and Duct Ectasia With Secretion.
Tek C, Öztekin PS, Celepli P, et al.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2021; (40(2)):269-277 doi:10.1002/jum.15396.
PMID: 32681668 - 10
Differential Diagnosis of Benign and Malignant Breast Papillary Neoplasms on MRI With Non-mass Enhancement.
Zhou J, Li M, Liu D, et al.
Academic radiology 2023; (30 Suppl 2()):S127-S132 doi:10.1016/j.acra.2023.02.010.
PMID: 36906443 - 11
Ultrasound-guided 7-gauge vacuum-assisted core biopsy: Could it be sufficient for the diagnosis and treatment of intraductal papilloma?
Wang ZL, Liu G, He Y, et al.
The breast journal 2019; (25(5)):807-812 doi:10.1111/tbj.13342.
PMID: 31131512 - 12
The Evolving Role of Vacuum Assisted Biopsy of the Breast: A Progression from Fine-Needle Aspiration Biopsy.
Bennett IC, Saboo A
World journal of surgery 2019; (43(4)):1054-1061 doi:10.1007/s00268-018-04892-x.
PMID: 30617562 - 13
Breast papillary lesions diagnosed and treated using ultrasound-guided vacuum-assisted excision.
Li X, Gao H, Xu M, et al.
BMC surgery 2020; (20(1)):204 doi:10.1186/s12893-020-00869-7.
PMID: 32933518 - 14
Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis.
Zhang X, Liu W, Hai T, Li F
Annals of surgical oncology 2021; (28(13)):8643-8650 doi:10.1245/s10434-021-10188-7.
PMID: 34331160 - 15
Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta-analysis.
Keating N, Cevik J, Hopkins D, Lippey J
Journal of surgical oncology 2024; (129(6)):1025-1033 doi:10.1002/jso.27592.
PMID: 38305061 - 16
Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors.
Corbin H, Bomeisl P, Amin AL, et al.
Human pathology 2022; (128()):90-100 doi:10.1016/j.humpath.2022.07.012.
PMID: 35863513 - 17
Pathologic High-risk Lesions, Diagnosis and Management.
Murray M
Clinical obstetrics and gynecology 2016; (59(4)):727-732 doi:10.1097/GRF.0000000000000234.
PMID: 27681693 - 18
Papillary Neoplasms of the Breast: WHO Classification, Multimodality Imaging, and Radiologic-Pathologic Correlation.
Thai JN, Vickery J, Boyraz B, et al.
Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(8)):e240091 doi:10.1148/rg.240091.
PMID: 40674246 - 19
The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034).
Nakhlis F, Baker GM, Pilewskie M, et al.
Annals of surgical oncology 2021; (28(5)):2573-2578 doi:10.1245/s10434-020-09215-w.
PMID: 33047246
This page is for informational purposes only and does not constitute medical advice about intraductal breast papillomatosis. Your breast radiologist, pathologist, and treating clinician should interpret your imaging and biopsy results and recommend next steps.